
Altius Institute for Biomedical Sciences
Altius Institute for Biomedical Sciences
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Altius Institute for Biomedical Sciences? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.
About
ALTIUS DIRECTLY CONDUCTS AN ACTIVE AND MULTIFACETED PROGRAM OF BIOTECHNOLOGY RESEARCH. WE CONDUCT A CONSIDERABLE MAJORITY OF RESEARCH PROGRAMS DIRECTLY IN OUR OWN RESEARCH LABORATORY FACILITY, LOCATED IN SEATTLE. THE MEDICAL RESEARCH ORGANIZATION PROGRAM IS INTENDED TO GENERATE, DEVELOP AND TRANSLATE TO CLINICAL USE REGULATORY GENOMIC AND OTHER TECHNOLOGIES THAT HAVE TRANSFORMATIVE POTENTIAL IN BASIC BIOLOGY, BIOMEDICINE AND PHARMACEUTICAL DEVELOPMENT AND VALIDATION. INITIAL EFFORTS OF OUR RESEARCH PROGRAM FOCUS ON DEVELOPING A RICHER UNDERSTANDING OF HUMAN CELL MODELS, TARGETS AND MECHANISMS, FOR THE PURPOSE OF DEVELOPING NEW THERAPIES FOR DISEASE. TO THIS END, THE ORGANIZATION WILL FOCUS DEVELOPMENT ON DRIVING THE SCALING AND TRANSLATIONAL VALIDATION OF EXISTING CUTTING EDGE RESEARCH PLATFORMS, INCLUDING REGULATORY GENOMIC ANALYSES AND GENOME ENGINEERING TECHNOLOGIES. REGULATORY GENOMIC ANALYSIS YIELDS A HIGH-CONTENT, QUANTITATIVE ASSESSMENT OF INDIVIDUAL REGULATORY ELEMENTS, WHICH PROVIDES HIGHLY SENSITIVE MARKERS OF CELLULAR RESPONSE TO DISEASE AND TO CURRENT AND PAST DRUG EXPOSURES. SUCH ASSESSMENTS INFORM WHAT TISSUE AND TARGET TO STUDY, HOW TO MODULATE A DRUG TARGET, ANTICIPATE OFF-TARGET EFFECTS, AND PROTOTYPE DRUG TREATMENT EFFECTS.
Interesting data from their 2019 990 filing
The non-profit's mission is outlined in the filing as being “The mission of the altius institute for biomedical sciences (altius) is to radically enable and advance biomedical discovery through the development and exploratory application of new technologies and approaches for illuminating cell and tissue states and function. to achieve this vision, altius is establishing a wholly new type of scientific and technological discovery environment designed to foster leaps in innovation. altius will leverage its cutting-edge technologies to span the chasm between basic biological discoveries related to the function of cells and tissues and the translation of these insights into the clinical arena and the development of novel medicines.”.
When outlining its responsibilities, they were referred to as: “To radically enable and advance biomedical discovery through the development and exploratory application of new technologies and approaches for illuminating cell and tissue states and function. to achieve this vision, altius is establishing a wholly new type of scientific and technological discovery environment designed to foster leaps in innovation. altius will leverage its cutting-edge technologies to span the chasm between basic biological discoveries related to the function of cells and tissues and the translation of these insights into the clinical arena and the development of novel medicines.”.
- The state in which the non-profit operates has been officially reported as DE.
- The filing reveals the non-profit's address in 2019 to be 2211 ELLIOTT AVENUE NO 410, SEATTLE, WA, 98121.
- As per the non-profit's form for 2019, they have 89 employees on their payroll.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $955,080.
- The organization has 4 independent voting members.
- The organization was formed in 2014.
- The organization pays $11,151,671 in salary, compensation, and benefits to its employees.
- The organization pays $0 in fundraising expenses.